These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9350901)

  • 1. Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I.
    Mayatepek E; Schröder M; Kohlmüller D; Bieger WP; Nützenadel W
    Acta Paediatr; 1997 Oct; 86(10):1138-40. PubMed ID: 9350901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose supplementation in carbohydrate-deficient glycoprotein syndrome type I and phosphomannomutase deficiency.
    Mayatepek E; Kohlmüller D
    Eur J Pediatr; 1998 Jul; 157(7):605-6. PubMed ID: 9686827
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).
    Carchon H; Van Schaftingen E; Matthijs G; Jaeken J
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):155-65. PubMed ID: 10571009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsuccessful intravenous D-mannose treatment in PMM2-CDG.
    Grünert SC; Marquardt T; Lausch E; Fuchs H; Thiel C; Sutter M; Schumann A; Hannibal L; Spiekerkoetter U
    Orphanet J Rare Dis; 2019 Oct; 14(1):231. PubMed ID: 31640729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins.
    Jaeken J; Artigas J; Barone R; Fiumara A; de Koning TJ; Poll-The BT; de Rijk-van Andel JF; Hoffmann GF; Assmann B; Mayatepek E; Pineda M; Vilaseca MA; Saudubray JM; Schlüter B; Wevers R; Van Schaftingen E
    J Inherit Metab Dis; 1997 Jul; 20(3):447-9. PubMed ID: 9266378
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbohydrate-deficient glycoprotein syndrome: beyond the screen.
    Fletcher JM; Matthijs G; Jaeken J; Van Schaftingen E; Nelson PV
    J Inherit Metab Dis; 2000 Jun; 23(4):396-8. PubMed ID: 10896303
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity.
    Freeze HH; Aebi M
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):167-78. PubMed ID: 10571010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.
    de Koning TJ; Dorland L; van Diggelen OP; Boonman AM; de Jong GJ; van Noort WL; De Schryver J; Duran M; van den Berg IE; Gerwig GJ; Berger R; Poll-The BT
    Biochem Biophys Res Commun; 1998 Apr; 245(1):38-42. PubMed ID: 9535779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate-deficient glycoprotein syndrome type 1: correction of the glycosylation defect by deprivation of glucose or supplementation of mannose.
    Körner C; Lehle L; von Figura K
    Glycoconj J; 1998 May; 15(5):499-505. PubMed ID: 9881752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.
    Van Schaftingen E; Jaeken J
    FEBS Lett; 1995 Dec; 377(3):318-20. PubMed ID: 8549746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Skin manifestations of protein glycosylation deficiency, the CDG (carbohydrate deficient glycoprotein) type 1 syndrome].
    Vabres P; Sevin C; Amoric JC; Odièvre MH; Saudubray JM; de Prost Y
    Ann Dermatol Venereol; 1998 Oct; 125(10):715-6. PubMed ID: 9835963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients.
    Freeze HH
    Biochim Biophys Acta; 2009 Sep; 1792(9):835-40. PubMed ID: 19339218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A.
    Kjaergaard S; Kristiansson B; Stibler H; Freeze HH; Schwartz M; Martinsson T; Skovby F
    Acta Paediatr; 1998 Aug; 87(8):884-8. PubMed ID: 9736238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance.
    Jaeken J; Pirard M; Adamowicz M; Pronicka E; van Schaftingen E
    Pediatr Res; 1996 Nov; 40(5):764-6. PubMed ID: 8910943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency).
    Barone R; Carchon H; Jansen E; Pavone L; Fiumara A; Bosshard NU; Gitzelmann R; Jaeken J
    J Inherit Metab Dis; 1998 Apr; 21(2):167-72. PubMed ID: 9584269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital disorder of glycosylation Ia with deficient phosphomannomutase activity but normal plasma glycoprotein pattern.
    Dupre T; Cuer M; Barrot S; Barnier A; Cormier-Daire V; Munnich A; Durand G; Seta N
    Clin Chem; 2001 Jan; 47(1):132-4. PubMed ID: 11148191
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal metabolism of mannose in families with carbohydrate-deficient glycoprotein syndrome type 1.
    Panneerselvam K; Etchison JR; Skovby F; Freeze HH
    Biochem Mol Med; 1997 Aug; 61(2):161-7. PubMed ID: 9259981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
    Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
    Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and potential strategies for the treatment of PMM2-CDG.
    Gámez A; Serrano M; Gallego D; Vilas A; Pérez B
    Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129686. PubMed ID: 32712172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG).
    Taday R; Grüneberg M; DuChesne I; Reunert J; Marquardt T
    Orphanet J Rare Dis; 2020 Sep; 15(1):258. PubMed ID: 32962735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.